Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;66(9):e27827.
doi: 10.1002/pbc.27827. Epub 2019 Jun 10.

Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group

Uma Athale  1 , Nobuko Hijiya  2 , Briana C Patterson  3   4 , John Bergsagel  4 , Jeffrey R Andolina  5 , Henrique Bittencourt  6 , Kirk R Schultz  7 , Michael J Burke  8 , Michele S Redell  9 , E Anders Kolb  10 , Donna L Johnston  11
Affiliations
Review

Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group

Uma Athale et al. Pediatr Blood Cancer. 2019 Sep.

Abstract

Chronic myeloid leukemia (CML) accounts for 2-3% of leukemias in children under 15 and 9% in adolescents aged 15-19. The diagnosis and management of CML in children, adolescents, and young adults have several differences compared to that in adults. This review outlines the diagnosis and management of the underlying disease as well as challenges that can occur when dealing with CML in this patient population.

Keywords: CML; pediatric; recommendations.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors have no conflict of interest to declare.

References

    1. Hijiya N, Schultz KR, Metzler M, Millot F, Suttorp M. Pediatric chronic myeloid leukemia is a unique disease that requires a different approach. Blood 2016;127:392–399. - PMC - PubMed
    1. Hijiya N, Millot F, Suttorp M: Chronic myeloid leukemia in children: Clinical findings, management, and unanswered questions. Pediatr Clin North Am 2015;62:107–119. - PubMed
    1. Mattano L, Nachman J, Ross J, Stock W. Leukemias In: Bleyer A, O’Leary M, Barr R, Ries LAG (eds): Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975–2000. National Cancer Institute, NIH Pub. No. 06–5767. Bethesda, MD: 2006; pages 39–51. https://seer.cancer.gov/archive/publications/aya/aya_mono_complete.pdf Access date December 2018
    1. Millot F, Traore P, Guilhhot J, et al. Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia. Pediatrics 2005;116:140–143. - PubMed
    1. Pemmaraju N, Kanarjian H, Shan J, et al. Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy. Haematologica 2012;97:1029–1035. - PMC - PubMed

Publication types